{"title":"开发和评估用于治疗幽门螺旋杆菌感染的新型阿莫西林和植酸胃粘膜黏附性果胶微粒","authors":"Ajit Mishra, Debalina Maity, Deepak Pradhan, Jitu Halder, Tushar Kanti Rajwar, Vineet Kumar Rai, Manoj Kumar Sarangi, Salim Manoharadas, Manish Ramchandani, Amit Goyal, Biswakanth Kar, Goutam Ghosh, Goutam Rath","doi":"10.1007/s12247-024-09820-2","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><p>Amoxicillin, a treatment option widely employed against <i>H. pylori</i> infection, is becoming ineffective due to the rising antimicrobial resistance. The poor stability of amoxicillin in gastric juice, as well as amoxicillin resistance in <i>H. pylori</i>, has a negative impact on amoxicillin’s therapeutic efficacy. Because of its metal chelating capacity, phytic acid has been shown to improve the antibacterial effectiveness of adjunct antimicrobials. Gastroretentive drug delivery carriers present a viable approach for treating gastric conditions owing to their higher gastric residence time and controlled drug release properties.</p><h3>Methods</h3><p>In the current investigation, amoxicillin and phytic acid loaded benzalkonium chloride (BAC) cross-linked pectin microparticles were prepared via ionic gelation technique with 83.65 ± 3.12% yield. Microparticles were evaluated based on drug release profile, drug degradation, permeation, mucoadhesion, β-lactamase inhibition, <i>in vitro</i> antimicrobial activity, <i>in vivo</i> gastro retention, <i>in vivo</i> gastroprotection and in vitro cytotoxicity parameters to ensure their therapeutic outcomes.</p><h3>Results</h3><p>In silico investigation predicted higher binding affinity (− 5.752 kcal/mol) of phytic acid with β-lactamase enzyme than clavulanic acid (− 4.870 kcal/mol). The microparticles that demonstrated 85.21 ± 1.12% entrapment efficiency and good mucoadhesive profile (~ 40%) showed high gastric stability and sustained release profile (~ 82% release in 14 h). SEM examination portrayed non-spherical particles with porous surfaces. FTIR and DSC analyses revealed no interaction between the drug and the polymer matrix. Microparticles were found to have superior β-lactamase inhibition potential and higher zone of inhibition (27.66 ± 2.49 mm)) compared with pure drug (18.33 ± 1.69). X-ray radiography study indicated that the prepared microparticles retained in the stomach for over 4 h.</p><h3>Conclusion</h3><p>In conclusion, provided with tremendous improvement in the drug’s stability in the gastric environment, these microparticles pose a viable option in the treatment of <i>H. pylori</i> infections.</p><h3>Graphical Abstract</h3>\n<div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":656,"journal":{"name":"Journal of Pharmaceutical Innovation","volume":"19 2","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2024-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Development and Evaluation of Novel Amoxicillin and Phytic Acid-Loaded Gastro-Retentive Mucoadhesive Pectin Microparticles for the Management of Helicobacter pylori Infections\",\"authors\":\"Ajit Mishra, Debalina Maity, Deepak Pradhan, Jitu Halder, Tushar Kanti Rajwar, Vineet Kumar Rai, Manoj Kumar Sarangi, Salim Manoharadas, Manish Ramchandani, Amit Goyal, Biswakanth Kar, Goutam Ghosh, Goutam Rath\",\"doi\":\"10.1007/s12247-024-09820-2\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Purpose</h3><p>Amoxicillin, a treatment option widely employed against <i>H. pylori</i> infection, is becoming ineffective due to the rising antimicrobial resistance. The poor stability of amoxicillin in gastric juice, as well as amoxicillin resistance in <i>H. pylori</i>, has a negative impact on amoxicillin’s therapeutic efficacy. Because of its metal chelating capacity, phytic acid has been shown to improve the antibacterial effectiveness of adjunct antimicrobials. Gastroretentive drug delivery carriers present a viable approach for treating gastric conditions owing to their higher gastric residence time and controlled drug release properties.</p><h3>Methods</h3><p>In the current investigation, amoxicillin and phytic acid loaded benzalkonium chloride (BAC) cross-linked pectin microparticles were prepared via ionic gelation technique with 83.65 ± 3.12% yield. Microparticles were evaluated based on drug release profile, drug degradation, permeation, mucoadhesion, β-lactamase inhibition, <i>in vitro</i> antimicrobial activity, <i>in vivo</i> gastro retention, <i>in vivo</i> gastroprotection and in vitro cytotoxicity parameters to ensure their therapeutic outcomes.</p><h3>Results</h3><p>In silico investigation predicted higher binding affinity (− 5.752 kcal/mol) of phytic acid with β-lactamase enzyme than clavulanic acid (− 4.870 kcal/mol). The microparticles that demonstrated 85.21 ± 1.12% entrapment efficiency and good mucoadhesive profile (~ 40%) showed high gastric stability and sustained release profile (~ 82% release in 14 h). SEM examination portrayed non-spherical particles with porous surfaces. FTIR and DSC analyses revealed no interaction between the drug and the polymer matrix. Microparticles were found to have superior β-lactamase inhibition potential and higher zone of inhibition (27.66 ± 2.49 mm)) compared with pure drug (18.33 ± 1.69). X-ray radiography study indicated that the prepared microparticles retained in the stomach for over 4 h.</p><h3>Conclusion</h3><p>In conclusion, provided with tremendous improvement in the drug’s stability in the gastric environment, these microparticles pose a viable option in the treatment of <i>H. pylori</i> infections.</p><h3>Graphical Abstract</h3>\\n<div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>\",\"PeriodicalId\":656,\"journal\":{\"name\":\"Journal of Pharmaceutical Innovation\",\"volume\":\"19 2\",\"pages\":\"\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2024-02-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Pharmaceutical Innovation\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://link.springer.com/article/10.1007/s12247-024-09820-2\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmaceutical Innovation","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s12247-024-09820-2","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
Development and Evaluation of Novel Amoxicillin and Phytic Acid-Loaded Gastro-Retentive Mucoadhesive Pectin Microparticles for the Management of Helicobacter pylori Infections
Purpose
Amoxicillin, a treatment option widely employed against H. pylori infection, is becoming ineffective due to the rising antimicrobial resistance. The poor stability of amoxicillin in gastric juice, as well as amoxicillin resistance in H. pylori, has a negative impact on amoxicillin’s therapeutic efficacy. Because of its metal chelating capacity, phytic acid has been shown to improve the antibacterial effectiveness of adjunct antimicrobials. Gastroretentive drug delivery carriers present a viable approach for treating gastric conditions owing to their higher gastric residence time and controlled drug release properties.
Methods
In the current investigation, amoxicillin and phytic acid loaded benzalkonium chloride (BAC) cross-linked pectin microparticles were prepared via ionic gelation technique with 83.65 ± 3.12% yield. Microparticles were evaluated based on drug release profile, drug degradation, permeation, mucoadhesion, β-lactamase inhibition, in vitro antimicrobial activity, in vivo gastro retention, in vivo gastroprotection and in vitro cytotoxicity parameters to ensure their therapeutic outcomes.
Results
In silico investigation predicted higher binding affinity (− 5.752 kcal/mol) of phytic acid with β-lactamase enzyme than clavulanic acid (− 4.870 kcal/mol). The microparticles that demonstrated 85.21 ± 1.12% entrapment efficiency and good mucoadhesive profile (~ 40%) showed high gastric stability and sustained release profile (~ 82% release in 14 h). SEM examination portrayed non-spherical particles with porous surfaces. FTIR and DSC analyses revealed no interaction between the drug and the polymer matrix. Microparticles were found to have superior β-lactamase inhibition potential and higher zone of inhibition (27.66 ± 2.49 mm)) compared with pure drug (18.33 ± 1.69). X-ray radiography study indicated that the prepared microparticles retained in the stomach for over 4 h.
Conclusion
In conclusion, provided with tremendous improvement in the drug’s stability in the gastric environment, these microparticles pose a viable option in the treatment of H. pylori infections.
期刊介绍：
The Journal of Pharmaceutical Innovation (JPI), is an international, multidisciplinary peer-reviewed scientific journal dedicated to publishing high quality papers emphasizing innovative research and applied technologies within the pharmaceutical and biotechnology industries. JPI''s goal is to be the premier communication vehicle for the critical body of knowledge that is needed for scientific evolution and technical innovation, from R&D to market. Topics will fall under the following categories:
Materials science,
Product design,
Process design, optimization, automation and control,
Facilities; Information management,
Regulatory policy and strategy,
Supply chain developments ,
Education and professional development,
Journal of Pharmaceutical Innovation publishes four issues a year.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
